Overview

dCELL Technology is a gentle, soft tissue decellularization process, removing DNA and cellular material to reduce the risk of rejection.  

dCELL Technology...... because not all decellularization processing is the same.  

• Utilizes extremely low concentrations of single anionic detergent to remove donor cells and cellular debris.
• Utilizes a nuclease treatment that results in greater than 99% DNA removal.
•  Use of protease inhibitors helps preserve native tissue structure and biomechanical properties.
• Terminally irradiated to provide sterility assurance level (SAL) 10-6. 

DermaPure, all configurations, is a human-derived dermal allograft, created using dCELL Technology, allowing the  dermal tissue to maintain its structure and biomechanical properties.  The result is a versatile, intact extracellular matrix.   Minimal DNA content after decellularization, sets DermaPure apart.  dCELL Technology is the difference.